Summary
A 34-year-old vice president and technology officer for a defense contractor was denied a security clearance under Guideline H (Drug Involvement). The Statement of Reasons alleged extensive drug use, including marijuana from 1976 to at least October 1996, and its purchase from 1977 to at least October 1996. Further allegations included cocaine use about 10 times between 1980 and 1981, LSD around twenty times in the same period, and hashish between 10 and 15 times from 1977 to the early 1980s.
The applicant was also alleged to have used opium about five times between 1977 and the early 1980s, and Quaaludes, Valium, and amphetamines between 1980 and 1986. Despite the applicant's claim of ceasing marijuana use in 1991, the judge found his credibility undermined by ambiguous testimony and evidence indicating continued drug use until October 1996.
The denial was based on the recency of drug use, occurring as late as October 1996, and the applicant's ambiguous testimony, which raised doubts about his credibility. Additionally, the applicant failed to provide independent evidence to support his claims of drug use cessation.
Why the Applicant Was Denied
- The applicant's drug use was recent, occurring as late as October 1996.
- Ambiguous testimony regarding drug use raised doubts about the applicant's credibility.
- The applicant failed to provide independent evidence to support claims of cessation of drug use.
Conditions Referenced
- H1raisedDrug Involvement
Key Rule Quoted
“The granting (or continuance) of a security clearance under this Directive may only be done upon a finding that to do so is clearly consistent with the national interest.”
Procedural Posture
- SOR issuedApr 15, 1997
- Answer filedMay 14, 1997
- Hearing heldAug 7, 1997
- Decision dateOct 22, 1997
Cite For
- Credibility Issues Related to Drug Use Under Guideline H
- Recent Drug Involvement as a Basis for Denial
- The Importance of Independent Evidence in Mitigating Drug Use Concerns